Technology Solutions

BioClinica introduces StudyView for trials operational visibility

Wednesday, June 26, 2013 02:45 PM

BioClinica, a global provider of clinical trial management solutions, has introduced StudyView, a clinical trials portal and reporting hub that increases clinical trials operational visibility. StudyView provides one tool to access multiple eClinical applications, as well as analyze and report data across studies. Data visualization tools use real-time data for analytics, informing operational decisions about clinical studies. StudyView is fully integrated with BioClinica's product suite and is 21 CFR Part 11 compliant.

More... »

Datatrak introduces One Clinical ERP solution DIA

Monday, June 24, 2013 03:10 PM

Cleveland-based Datatrak International, a developer of cloud-based, unified eClinical technologies and related services for the clinical trials industry, announced its next-generation clinical trial management enterprise resource planning (ERP) solution. The Datatrak One Clinical ERP release streamlines the clinical trial process through enhancements to DATATRAK's single database architecture. 

More... »

goBalto creates customer success division

Friday, June 21, 2013 03:15 PM

San Francisco-based goBalto has announced a new Customer Success division, designed to nurture and expand customer relationships through consultative account management and ensure continuous customer enthusiasm.

More... »

Instem enters early phase market

Friday, June 21, 2013 03:13 PM

Instem of Conshohocken, Pa., a provider of IT solutions to the global early development healthcare market, has entered the early phase clinical trials market with its recent acquisition of Logos Technologies.

More... »

Astellas Pharma joins SAFE-BioPharma

Friday, June 21, 2013 01:21 PM

Astellas Pharma has joined the SAFE-BioPharma Association, a nonprofit industry coalition responsible for the ongoing development and implementation of the global SAFE-BioPharma digital identity and signature standard. As a member, Astellas is able to utilize the SAFE-BioPharma standard. It is the first Japanese pharmaceutical company to become a member.

More... »

Comprehend Systems partners with Merge Healthcare

Friday, June 21, 2013 01:03 PM

Palo Alto-based Comprehend Systems has expanded its reach in the clinical research space with a partnership with Merge Healthcare’s eClinical Solutions division. The integration of Comprehend Clinical with Merge’s eClinical OS will enable Merge’s growing base of sponsor and CRO customers to gain critical insights into end-to-end clinical and operational data, without the need for costly programming, data warehousing or business intelligence (BI) tools. 

More... »

ERT announces enhancements on AVERT

Thursday, June 20, 2013 08:02 AM

ERT, a global solution provider for patient safety and efficacy endpoint data collection, has announced enhancements to AVERT, its electronic suicide risk assessment system. Having captured over 100,000 assessments to date, AVERT is a tool for biopharmaceutical developers who need to assess for suicide risk during clinical development programs.

More... »

Greenphire, IMS Health integrate eClinicalGPS and GrantPlan

Wednesday, June 19, 2013 11:49 AM

Greenphire has launched a strategic integration of its eClinicalGPS, a global investigator payment technology, with IMS Health’s GrantPlan, a benchmarking and contracting tool for global clinical site grants.

More... »

DigiCert, DataMotion partner for secure health information exchange

Thursday, June 13, 2013 11:30 AM

DigiCert, a high-assurance digital certificate provider, and DataMotion, a health information service provider (HISP) with 14 years of experience in secure data delivery services, have partnered to expand common dual-mode certification for commercial and federal use for the healthcare industry. The partnership plans to improve patient care by making it much simpler for federal and non-federal organizations to engage in the secure electronic exchange of healthcare information.

More... »

ExpreS2ion Biotechnologies, Cancer Research U.K. enter license agreement

Monday, June 10, 2013 11:35 AM

ExpreS²ion Biotechnologies has signed a research license agreement to provide the Protein Purification Facility at Cancer Research U.K.’s London Research Institute with access to its Drosophila Schneider-2 cell-based technology platform—ExpreS²—for protein production.

More... »